Karl AIGNER | Head of Department | Professor Dr | Medias Klinikum, Burghausen | Department of Surgical Oncology | Research profile
Medias Klinikum GmbH & Co. KG Reviews & Experiences
Krebstherapie Burghausen – Prof. Dr. med. Karl R. Aigner
The world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat ... | Presseportal
Prof. Dr. med. Karl R. Aigner
Karl R. Aigner, Prof. Dr. – Ärztlicher Direktor, Chefarzt und geschäftsführender Gesellschafter – Medias Klinikum | LinkedIn
PDF) Intra-arterial infusion chemotherapy versus isolated upper abdominal perfusion for advanced pancreatic cancer: a retrospective cohort study on 454 patients
Krebstherapie Burghausen – Prof. Dr. med. Karl R. Aigner
Krebstherapie Burghausen – Prof. Dr. med. Karl R. Aigner
Karl AIGNER | Head of Department | Professor Dr | Medias Klinikum, Burghausen | Department of Surgical Oncology | Research profile
Prof. Dr. med. Karl R. Aigner
Team - medias-klinikum
Prof. Dr. med. Karl R. Aigner
Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos
Regionale Chemotherapie mit EISLI
Onkologie Basiswissen | SpringerLink
Team - medias-klinikum
Prof. Dr. med. Karl R. Aigner
Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos
Team - medias-klinikum
Burghausen Cancer Therapy – Prof. Dr Karl R. Aigner
Regionale Chemotherapie beim Zervixkarzinom
Karl AIGNER | Head of Department | Professor Dr | Medias Klinikum, Burghausen | Department of Surgical Oncology | Research profile
Oncological Clinic Medias Burghausen
Burghausen Cancer Therapy – Prof. Dr Karl R. Aigner
